For systemically secreted proteins such as EPO, precise regulation of gene expression in normal and unhealthy ganglion cells is needed, as dysregulation of EPO expression could cause lethal adverse events, such as polycythemia or thromboembolic events. This evidence concerns the gene EPO and polycythemia.